Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: HandsOn who wrote (2104)	12/2/1998 10:50:00 AM
From: Scott A. Trapp	Respond to of 90042

FYI From the Microsoft Investor site: CIEN CIENA current price: $19.13 First support for CIENA: $14.33 (50-day moving average) First resistance for CIENA: $43.25 (200-day moving average)

To: HandsOn who wrote (2104)	12/2/1998 12:30:00 PM
From: Captain Ed	Read Replies (1) \| Respond to of 90042

TGX, an anti cancer treatment company with real earnings, is up nicely today. News coming?? Does anyone know why this company is making a nice move up today?? Business Summary Theragenics Corporation develops, manufactures, and markets implantable radiation devices (seeds) for the treatment of prostate cancer. For the 9 months ended 9/30/98, revenues rose 63% to $28.1M. Net income rose 71% to $10.7M. Revenues reflect increased production volume of Theraseed(R) and increased patient awareness of the Theraseed(R) procedure. Earnings reflect the sales and marketing agreement with Indigo Medical, Inc.